ECS Botanics Holdings (ASX:ECS) OCF Margin %: 3.17% (As of Dec. 2025)


What is ECS Botanics Holdings OCF Margin %?

ECS Botanics Holdings ASX:ECS -11.11% OCF Margin % is 3.17% as of Dec. 2025. The stock has 9 warning signs investors should review. Among 959 Drug Manufacturers companies, ECS Botanics Holdings ranks worse than 85.71% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ECS Botanics Holdings's Cash Flow from Operations for the six months ended in Dec. 2025 was A$0.36 Mil. ECS Botanics Holdings's Revenue for the six months ended in Dec. 2025 was A$11.34 Mil. Therefore, ECS Botanics Holdings's OCF Margin % for the quarter that ended in Dec. 2025 was 3.17%.

As of today, ECS Botanics Holdings's current OCF Yield % is -49.14%.

The historical rank and industry rank for ECS Botanics Holdings's OCF Margin % or its related term are showing as below:

ASX:ECS' s OCF Margin % Range Over the Past 10 Years
Min: -566.18   Med: -69.56   Max: 2.62
Current: -16.83

During the past 13 years, the highest OCF Margin % of ECS Botanics Holdings was 2.62%. The lowest was -566.18%. And the median was -69.56%.

ASX:ECS's OCF Margin % is ranked worse than
85.71% of 959 companies
in the Drug Manufacturers industry
Industry Median: 9.95 vs ASX:ECS: -16.83

ECS Botanics Holdings OCF Margin % Related Terms

ECS Botanics Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for ECS Botanics Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ECS Botanics Holdings OCF Margin % Chart

ECS Botanics Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -181.56 -69.56 2.62 -7.42 -26.19

ECS Botanics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.75 -21.83 -12.16 -40.39 3.17

ASX:ECS vs ZTS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ECS Botanics Holdings OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where ECS Botanics Holdings's OCF Margin % falls into.


ECS Botanics Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ECS Botanics Holdings's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-5.072/19.363
=-26.19 %

ECS Botanics Holdings's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.36/11.342
=3.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 3.17% mean?
ECS Botanics Holdings (ASX:ECS) has a OCF Margin % of 3.17% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ECS Botanics Holdings and its competitors. According to the industry distribution chart, ECS Botanics Holdings ranks #822 out of 959 companies in the Drug Manufacturers industry, placing it in the top 85.7%.
Is ECS Botanics Holdings' OCF Margin % too high?
ECS Botanics Holdings' current OCF Margin % is 3.17%. The Drug Manufacturers industry median OCF Margin % is 9.95. ECS Botanics Holdings' value of 3.17% is 68.1% below this industry median. Based on the distribution chart, ECS Botanics Holdings ranks #822 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does ECS Botanics Holdings' OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, ECS Botanics Holdings ranks #822 out of 959 companies for OCF Margin %. This places ECS Botanics Holdings in the lower half of its industry. The industry median OCF Margin % is 9.95. ECS Botanics Holdings' value of 3.17% is 68.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ECS Botanics Holdings's current OCF Margin % of 3.17% is 68.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ECS Botanics Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ECS Botanics Holdings's current OCF Margin % is 3.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ECS Botanics Holdings stock overvalued right now?
Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current OCF Margin % is 3.17% and 68.1% below the Drug Manufacturers industry median of 9.95. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current OCF Margin % is 3.17% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ECS Botanics Holdings Business Description

Address 899 River Road, Murrabit West, Murrabit, VIC, AUS, 3579
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.